C4D Partners

Indonesia
cb
Founded:2013
Firm Location:Indonesia • India • Mumbai, India
C4D Partners Team
Photo of Arvind Agarwal, Investor at C4D Partners
Arvind Agarwal
C4D Partners·Investor
Sweet spot: $600K
Range: $200K - $1M
Investors in India
Investors in AgTech (Series B), Investors in EnergyTech (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B)
to see your intro paths to Arvind
Photo of Sowmya Arunkumar, Associate at C4D Partners
Sowmya Arunkumar
C4D Partners·Associate
Sweet spot: $600K
Range: $200K - $1M
Investors in India
Investors in AgTech (Series B), Investors in Education (Series B), Investors in EnergyTech (Series B), Investors in Pharmaceuticals (Series B)
to see your intro paths to Sowmya
Photo of Kathryn Durando, Investor at C4D Partners
Kathryn Durando
C4D Partners·Investor
Sweet spot: $600K
Range: $200K - $1M
Investors in India
Investors in AgTech (Series B), Investors in Education (Series B), Investors in EnergyTech (Series B), Investors in Pharmaceuticals (Series B)
to see your intro paths to Kathryn
Photo of Manish Kumar, Principal at C4D Partners
Manish Kumar
C4D Partners·Principal
Sweet spot: $600K
Range: $200K - $1M
Investors in Mumbai (India)
Investors in AgTech (Series B), Investors in Education (Series B), Investors in EnergyTech (Series B), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B)
to see your intro paths to Manish
Photo of Gisela Ludiarto, Analyst at C4D Partners
Gisela Ludiarto
C4D Partners·Analyst
Sweet spot: $600K
Range: $200K - $1M
Investors in Indonesia
Investors in AgTech (Series B), Investors in Education (Series B), Investors in EnergyTech (Series B), Investors in Impact (Series B), Investors in Pharmaceuticals (Series B)
to see your intro paths to Gisela
Photo of Marcel Neutel, Partner at C4D Partners
Marcel Neutel
C4D Partners·Partner
Sweet spot: $600K
Range: $200K - $1M
Investors in Indonesia
Investors in AgTech (Series B), Investors in Education (Series B), Investors in EnergyTech (Series B), Investors in Impact (Series B), Investors in Pharmaceuticals (Series B)
to see your intro paths to Marcel